Hayabuchi N, Jingu K, Matsui M, Tamura S, Matsuura K, Komiyama S, Kikuchi M
Radiat Med. 1984 Oct-Dec;2(4):252-9.
The clinicopathologic data of 97 patients with non-Hodgkin's lymphomas involving Waldeyer's ring were retrospectively reviewed. Age, sex, the site of involvement within Waldeyer's ring, and Rappaport's histological classification played little role in the prognosis. Although the Ann Arbor staging classification was the only factor that correlated with the patients' prognoses (stage I vs stage II, p less than 0.01; stage II vs stage III + IV, p less than 0.02), it is not considered the ideal classification. The survival rates of stage II patients, who comprised about 60% of the entire group, was quite different due to their cervical node status. That is, 33 patients with bulky cervical nodes (4 cm in diameter or more) or bilateral cervical nodes had significantly poorer survival rates than 24 patients with small unilateral cervical nodes (p less than 0.001). The survival curve of the former group was similar to that of the stage III and IV patients, whereas the survival curve of the latter group was similar to that of the stage I patients. Lymphography, which was performed for 72 patients in this series, is not considered essential. From these results, we recommend the categorization of patients with malignant lymphomas involving Waldeyer's ring into two major groups according to cervical and inguinal node status in order to assess treatment methods. That is, patients with bulky or bilateral cervical lymph nodes or those with inguinal lymphadenopathy and patients without any lymphadenopathy or those with minimal unilateral cervical nodes alone.
对97例累及瓦尔代尔环的非霍奇金淋巴瘤患者的临床病理资料进行了回顾性分析。年龄、性别、瓦尔代尔环内的受累部位以及拉帕波特组织学分类对预后影响不大。虽然安阿伯分期分类是与患者预后相关的唯一因素(I期与II期,p<0.01;II期与III + IV期,p<0.02),但它并非理想的分类方法。占整个组约60%的II期患者的生存率因其颈部淋巴结状况而有很大差异。也就是说,33例有巨大颈部淋巴结(直径4厘米或更大)或双侧颈部淋巴结的患者的生存率明显低于24例有小的单侧颈部淋巴结的患者(p<0.001)。前一组的生存曲线与III期和IV期患者相似,而后一组的生存曲线与I期患者相似。本系列中72例患者进行了淋巴造影,但认为其并非必需。根据这些结果,我们建议根据颈部和腹股沟淋巴结状况将累及瓦尔代尔环的恶性淋巴瘤患者分为两大组,以便评估治疗方法。即有巨大或双侧颈部淋巴结的患者或有腹股沟淋巴结病的患者以及无任何淋巴结病或仅有最小单侧颈部淋巴结的患者。